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Singh et al S58.e2Background: Socioeconomic status (SES) has been associated with melanoma incidence and outcomes.
Examination of the relationship between melanoma and SES at the national level in the United States is
limited. Expanding knowledge of this association is needed to improve early detection and eliminate
disparities.Objective: We sought to provide a detailed description of cutaneous melanoma incidence and stage of
disease in relationship to area-based socioeconomic measures including poverty level, education, income,
and unemployment in the United States.Methods: Invasive cutaneous melanoma data reported by 44 population-based central cancer registries for
2004 to 2006 were merged with county-level SES estimates from the US Census Bureau. Age-adjusted
incidence rates were calculated by gender, race/ethnicity, poverty, education, income, unemployment, and
metro/urban/rural status using software. Poisson multilevel mixed models were fitted, and incidence
density ratios were calculated by stage for area-based SES measures, controlling for age, gender, and state
random effects.Results: Counties with lower poverty, higher education, higher income, and lower unemployment had
higher age-adjusted melanoma incidence rates for both early and late stage. In multivariate models, SES
effects persisted for early-stage but not late-stage melanoma incidence.Limitations: Individual-level measures of SES were unavailable, and estimates were based on county-level
SES measures.Conclusion: Our findings show that melanoma incidence in the United States is associated with aggregate
county-level measures of high SES. Analyses using finer-level SES measures, such as individual or census
tract level, are needed to provide more precise estimates of these associations. ( J Am Acad Dermatol
2011;65:S58.e1-12.)
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S58.e3 Singh et alstill persist in cancer incidence, mortality, and sur-
vival.1 Socioeconomic status (SES) is a keymarker for
the development of cancer and subsequently stage
of diagnosis2-4 and is often measured by a combina-
tion of income, education, occupation, race, place of
residence, and poverty level.5-7 SES measures are
associated with variations in cutaneous melanomaCAPSULE SUMMARY
d Non-Hispanic whites have the highest
early- and late-stage age-adjusted
cutaneous melanoma incidence rates.
d Low poverty, high education, high
income, low unemployment, and
metropolitan counties have the highest
incidence of melanoma overall and for
early-stage cases.
d In multivariate models, late-stage
cutaneous melanoma incidence did not
differ significantly by the county-level
socioeconomic status factors we
investigated.(hereafter called melanoma)
incidence and mortality.8-12
Previous studies in the
United States have docu-
mented disparities in the inci-
dence and mortality of
melanoma, specificallywithin
income and education strata.
Patients with higher SES
measures are more likely to
be given diagnoses of mela-
noma. In turn, those with
lower SES measures are
more likely tohavea late stage
at diagnosis, and worse out-
comes, including higher mor-
tality.8,9,11-19 Similar findings
have emerged from interna-
tional research conducted in
Australia and Sweden.13,20 Complicating our under-
standing of SES and melanoma epidemiology is the
complex relationship among socioeconomic factors,
environmental risk factors, sun-exposure behavior,21
awareness of melanoma prevention, access to pri-
mary care and melanoma screening,22-24 and poten-
tial variation in ultraviolet (UV) exposure related to
differences in outdoor recreation and leisure,25 a
product of SES itself. Intensive research efforts fo-
cusing on all aspects of melanoma are vital to
reducing the incidence and mortality associated
with the disease. Melanoma is the fastest growing
cancer worldwide,10 and incidence rates (IRs) con-
tinue to increase in the United States.26,27 Since the
1970s the incidence of melanoma has increased
approximately 3% to 4% per year.28 In 2006, 53,919
cases were diagnosed and 8441 deaths occurred as a
result of malignant melanoma.29 In addition to the
health burden, the economic cost of melanoma is
substantial. In 2000, it was estimated that the value
of life lost because of melanoma was $15.1 billion,
with a projected increase to $21.6 billion (42.8%)
by 2020.30
Because individual-level socioeconomic data are
not routinely available to cancer registries in the
United States from hospital records,4,5,31 thorough
examination of the relationship between melanoma
and SES measures using cancer registry data has
been difficult and limited. A detailed nationalexamination of the relationship between melanoma
and SES in the United States is needed to advance our
understanding of social determinants of melanoma
and ultimately improvemelanoma outcomes.8,10 The
objective of this study is to provide a population-
based, detailed analysis of melanoma incidence in the







For this study, melanoma
incidence data for diagnosis
years 2004 through 2006 col-
lected by population-based
central cancer registries
participating in the Centers
for Disease Control and
Prevention (CDC) National
Program of Cancer Registries
and the National Cancer
Institute (NCI) Surveillance,Epidemiology, and End Results (SEER) Program were
used. The National Program of Cancer Registries data
used were submitted in the 2009 National Program of
Cancer Registries Cancer Surveillance System Call for
Data and reported to CDC as of November 2008 or
January 31, 2009, whereas SEER data used were
reported to the NCI as of November 1, 2008. Please
refer to the methods paper in this supplement for
additional detail on participating state registries.32 For
this report, we excluded data from Kansas and
Minnesota because they do not submit county-level
data. New York, Texas, and Illinois chose not to
participate in this study. In addition, Arizona and
Wisconsin did notmeetUnited States Cancer Statistics
publication criteria for all the study years, hence,
were excluded from this study. Therefore, our report
includes data from 44 central cancer registries cover-
ing approximately 75% of the US population. These
registries released county-level data for incidence
and met established criteria for high-quality data.29
The data included were limited to microscopically
confirmed invasive melanoma cases among persons
aged 15 years and older. Analyses were restricted to
patients older than 15 years because of small case
counts in younger age groups (n = 334 cases).
Data measures
For these analyses, race and ethnicity variables
were combined to create 5 mutually exclusive
Abbreviations used:




NCI: National Cancer Institute
RUCC: rural-urban continuum codes
SEER: Surveillance, Epidemiology, and End
Results
SES: socioeconomic status
USDA: US Department of Agriculture
UV: ultraviolet
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Singh et al S58.e4race/ethnicity categories: non-Hispanic white;
Hispanic white; black; American Indian/Alaska
Native; and Asian/Pacific Islander. Initial analyses
were conducted using these 5 race/ethnicity groups.
However, because the majority of the cases (93%)
were diagnosed among non-Hispanic whites, more
detailed analyses were limited to non-Hispanic
whites. Stage at diagnosis was examined as all cases,
early stage and late stage using the Collaborative
Stage Derived SEER Summary Stage 2000 variable.33
‘‘All cases’’ included early stage, late stage, unknown
stage, and unstaged cases whereas ‘‘early stage’’
included only localized cases. Regional and distant-
stage cases were grouped as ‘‘late stage.’’
Socioeconomic measures were derived from the
US Census 200034 as provided by SEER.35 The use of
census-derived measures of SES has been validated
in previous studies.11,36,37 Poverty, education, in-
come, and unemployment were used as socioeco-
nomic measures of a county.2 Poverty was defined as
the percent of the county population below the
federal poverty level, and counties were categorized
as low (\10%), medium (10%-\20%), or high
($ 20%).38-40 High school education was defined
as the percent of the county population, aged 25
years and older, having attained a high school
diploma, and counties were categorized as low
(\75%), medium (75%-\85%), or high ($ 85%).
The county-level poverty and education variables
were available for all races combined and for race-
specific county measures. Race-specific county-level
education and poverty were used to analyze our data
for detailed analysis by race/ethnicity groups. The
median household income was categorized into 3
levels based on median household income reported
for each county: low (\$35,000), medium ($35,000-
\$50,000), and high ($ $50,000). Unemployment,
defined as the percent of the county civilian labor
force reporting being unemployed, was categorized
into low (\5%), medium (5%-10%), or high ([10%).
In addition, melanoma IRs were also examined
by metropolitan, urban, and rural classifications ofcounties,41 using the 2003 version of the US
Department of Agriculture (USDA) urban/rural con-
tinuum codes (RUCC). The USDA RUCC categorized
counties as metropolitan (RUCC 1-3), nonmetropol-
itan with urban populations (RUCC 4-7), or rural
(RUCC 8-9).
Analyses
Age-adjusted IRs. Age-adjusted melanoma IRs
and 95% confidence intervals (CI) were calculated in
SEER*Stat (version 6.5.2), a statistical software pack-
age developed by the NCI.42 We computed age-
adjusted melanoma IR and IR ratios for men and
women, aged 15 years and older, by race/ethnicity
groups and SES measures, including education, in-
come, poverty status, unemployment, and metro/
urban/rural status (Table I). Table II presents the
same analysis limited to non-Hispanic whites. These
rates were computed for all cases, early-stage dis-
ease, and late-stage disease. All rates were expressed
per 100,000 and were age-adjusted by the direct
method to the 2000 US standard population. The 95%
CI were estimated using the Tiwari method.
Multilevel modeling. Poisson multilevel mixed
models of melanoma incidence were calculated for
all stages combined and for early- and late-stage
melanoma cases using generalized linear mixed
models (SAS Proc Glimmix, Version 9.2, SAS
Institute Inc, Cary, NC). For these models, age was
aggregated into 3 groups (15-34, 35-64, and $ 65
years). The dependent variable was the count of
melanoma cases in each county by sex by race/
ethnicity by age group (hereafter referred to as
analysis cell), and the model was adjusted for the
number of expected cases. Expected case counts
were estimated using age- and sex-specific rates for
non-Hispanic whites for all states combined, thus
accounting for potential confounding by age and
sex. The expected analysis cell counts used the same
19 age groups as the age-adjusted IRs, aggregated
into the 3 coarser age groups. The data had a
hierarchical multilevel structure, with analysis cells
nested within counties, which were nested within
states. State of residence at the time of diagnosis was
included as a random effect in the models. This
helped account for state-level heterogeneity in inci-
dence, which may be related to melanoma incidence
data completeness and other differences among state
populations. Conditional on the state random effect
rates and the fixed effects at the county and analysis
cell levels, the observed cancer case counts were
assumed to be independent Poisson variables. A
covariance parameter was included in the models to
account for spatial autocorrelation. The models were
optimized using the Newton-Raphson technique
Table I. Age-adjusted incidence rates for all melanoma cases, early-stage melanoma, and late-stage melanoma by county-level socioeconomic status
measures among persons aged 15 years and older, United States 2004 to 2006
Area level characteristics
All cases Early stage Late stage
Cases Rate (95% CI) Rate ratio (95% CI) Cases Rate (95% CI) Rate ratio (95% CI) Cases Rate (95% CI) Rate ratio (95% CI)
Overall 130,359 24.2 (24.0-24.3) N/A 103,417 19.2 (19.1-19.3) N/A 16,940 3.1 (3.1-3.2) N/A
Sex
Male 73,818 30.2* (30.0-30.5) 1.52 (1.50-1.54) 57,522 23.5* (23.3-23.7) 1.45 (1.43-1.47) 10,723 4.4* (4.3-4.5) 2.07 (2.01-2.14)
Female 56,541 19.9 (19.8-20.1) 1 45,895 16.2 (16.1-16.3) 1 6217 2.1(2.1-2.2) 1
Race/ethnicity
Non-Hispanic white 121,253 29.4 (29.3-29.6) 1.00 96,654 23.5 (23.4-23.7) 1.00 15,927 3.8 (3.7-3.9) 1.00
Hispanic white 2262 5.9* (5.6-6.2) 0.20 (0.19-0.21) 1639 4.2* (4.0-4.4) 0.18 (0.17-0.19) 446 1.2* (1.1-1.3) 0.31 (0.28-0.35)
Black 681 1.3* (1.2-1.4) 0.04 (0.04-0.05) 363 0.7* (0.6-0.8) 0.03 (0.03-0.03) 243 0.5* (0.4-0.5) 0.12 (0.11-0.14)
American Indian/Alaska Native 240 5.7* (5.0-6.5) 0.19 (0.17-0.22) 158 3.6* (3.1-4.3) 0.15 (0.13-0.18) 51 1.3* (1.0-1.8) 0.35 (0.25-0.46)
Asian Pacific Islander 407 1.8* (1.6-2.0) 0.06 (0.05-0.07) 269 1.2* (1.0-1.3) 0.05 (0.04-0.06) 116 0.5* (0.4-0.6) 0.14 (0.11-0.17)
Below poverty level, %
Low (\10%) 57,999 27.6 (27.3-27.8) 1.00 45,922 21.8 (21.6-22.0) 1.00 7087 3.4 (3.3-3.4) 1.00
Medium (10%-\20%) 65,867 22.6* (22.4-22.7) 0.82 (0.81-0.83) 52,498 18.0* (17.9-18.2) 0.83 (0.82-0.84) 8891 3.0* (3.0-3.1) 0.90 (0.87-0.93)
High ($ 20%) 6035 15.9* (15.5-16.3) 0.58 (0.56-0.59) 4611 12.1* (11.8-12.5) 0.56 (0.54-0.57) 950 2.5* (2.3-2.7) 0.74 (0.69-0.80)
High school education, %
Low (\75%) 23,243 19.2 (19.0-19.5) 1.00 18,454 15.3 (15.0-15.5) 1.00 3428 2.8 (2.7-2.9) 1.00
Medium (75%-\85%) 63,383 23.9* (23.7-24.1) 1.24 (1.22-1.26) 50,068 18.9* (18.7-19.1) 1.24 (1.22-1.26) 8347 3.1* (3.1-3.2) 1.11 (1.06-1.15)
High ($ 85%) 43,275 28.2* (27.9-28.5) 1.47 (1.44-1.49) 34,509 22.5* (22.2-22.7) 1.47 (1.45-1.50) 5153 3.4* (3.3-3.5) 1.20 (1.14-1.25)
Median household income
Low (\$35,000) 22,222 19.9 (19.7-20.2) 1.00 16,958 15.3 (15.0-15.5) 1.00 3427 3.0 (2.9-3.1) 1.00
Medium ($35,000-\$50,000) 72,662 23.8* (23.6-24.0) 1.19 (1.18-1.21) 57,760 18.9* (18.8-19.1) 1.24 (1.22-1.26) 9438 3.1 (3.0-3.1) 1.01 (0.98-1.06)
High ($ $50,000) 35,017 28.5* (28.2-28.8) 1.43 (1.41-1.46) 28,313 23.0* (22.7-23.3) 1.51 (1.48-1.54) 4063 3.4* (3.3-3.5) 1.11 (1.06-1.16)
Unemployed, %
Low (\5%) 59,514 27.2* (27.0-27.5) 1.77 (1.71-1.83) 46,888 21.5* (21.3-21.7) 1.84 (1.77-1.91) 7346 3.4* (3.3-3.4) 1.32 (1.22-1.44)
Medium (5%-10%) 66,627 22.5* (22.3-22.6) 1.46 (1.41-1.51) 53,291 18.0* (17.8-18.1) 1.54 (1.48-1.60) 8963 3.0* (2.9-3.1) 1.19 (1.09-1.29)
High ([10%) 3759 15.4 (14.9-15.9) 1.00 2852 11.7 (11.3-12.1) 1.00 619 2.5 (2.3-2.7) 1.00
Metro/urban/rural status
Metropolitan 106,654 24.4* (24.2-24.5) 1.06 (1.05-1.08) 85,235 19.5* (19.4-19.6) 1.10 (1.08-1.12) 13,538 3.1* (3.0-3.2) 0.95 (0.91-0.99)
Urban 20,673 23.0 (22.7-23.3) 1.00 15,877 17.7 (17.4-18.0) 1.00 2976 3.3 (3.2-3.4) 1.00
Rural 2574 21.4* (20.6-22.3) 0.93 (0.89-0.97) 1919 15.9* (15.2-16.7) 0.90 (0.86-0.95) 414 3.5 (3.1-3.8) 1.06 (0.95-1.17)
Rates are per 100,000 and age-adjusted to 2000 US Standard Population (19 age groups; Census P25-1130) standard. Data are from 44 population-based cancer registries that participate in Centers
for Disease Control and Prevention National Program of Cancer Registries and National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) programs and provide county-level
incidence data.
Stage was coded using Collaborative Stage; data were recoded into Derived SEER Summary Stage 2000 for 2004 to 2006.
CI, Confidence interval; N/A, not applicable.




































Table II. Age-adjusted incidence rates for all melanoma cases, early-stage melanoma, and late-stage melanoma by county-level socioeconomic status
measures among non-Hispanic whites aged 15 years and older, United States 2004 to 2006
Area level characteristics
All cases Early stage Late stage
Cases Rate (95% CI) Rate ratio (95% CI) Cases Rate (95% CI) Rate ratio (95% CI) Cases Rate (95% CI) Rate ratio (95% CI)
Overall (white, non-Hispanic) 121,253 29.4 (29.3-29.6) N/A 96,654 23.5 (23.4-23.7) N/A 15,927 3.8 (3.7-3.9) N/A
Below poverty level, %*
Low (\10%) 93,964 30.6 (30.4-30.8) 1.00 75,191 24.6 (24.4-24.8) 1.00 11,988 3.9 (3.8-3.9) 1.00
Medium (10%-\20%) 25,787 25.8y (25.5-26.1) 0.84 (0.83-0.85) 20,274 20.3y (20.1-20.6) 0.83 (0.81-0.84) 3740 3.7y (3.6-3.8) 0.95 (0.92-0.99)
High ($ 20%) 1165 21.5y (20.3-22.8) 0.70 (0.66-0.74) 891 16.5y (15.4-17.6) 0.67 (0.63-0.72) 190 3.5 (3.0-4.1) 0.91 (0.78-1.05)
High school education, %*
Low (\75%) 8970 23.9 (23.4-24.4) 1.00 6951 18.6 (18.1-19.0) 1.00 1395 3.7 (3.5-3.9) 1.00
Medium (75%-\85%) 35,743 26.0y (25.7-26.3) 1.09 (1.06-1.11) 27,731 20.2y (20.0-20.5) 1.09 (1.06-1.12) 4995 3.6 (3.5-3.7) 0.97 (0.92-1.04)
High ($ 85%) 76,203 32.1y (31.9-32.4) 1.35 (1.32-1.38) 61,674 26.1y (25.9-26.3) 1.40 (1.37-1.44) 9528 4.0y (3.9-4.1) 1.08 (1.02-1.15)
Median household income
Low (\$35,000) 21,275 23.9 (23.6-24.3) 1.00 16,271 18.4 (18.1-18.7) 1.00 3276 3.6 (3.5-3.7) 1.00
Medium ($35,000-\$50,000) 67,188 29.1y (28.9-29.4) 1.22 (1.20-1.24) 53,716 23.4y (23.2-23.6) 1.27 (1.25-1.29) 8822 3.8y (3.7-3.9) 1.04 (1.00-1.09)
High ($ $50,000) 32,453 35.0y (34.6-35.4) 1.46 (1.44-1.49) 26,369 28.5y (28.1-28.8) 1.55 (1.52-1.58) 3820 4.1y (4.0-4.3) 1.14 (1.09-1.19)
Unemployed, %
Low (\5%) 56,020 30.1y (29.9-30.4) 1.30 (1.26-1.35) 44,394 23.9y (23.7-24.2) 1.34 (1.29-1.40) 7063 3.8 (3.7-3.8) 1.01 (0.92-1.11)
Medium (5%-10%) 61,596 29.0y (28.8-29.3) 1.26 (1.21-1.30) 49,429 23.4y (23.2-23.6) 1.31 (1.26-1.37) 8318 3.9 (3.8-3.9) 1.04 (0.95-1.13)
High ([10%) 3300 23.1 (22.3-23.9) 1.00 2533 17.8 (17.1-18.5) 1.00 537 3.7 (3.4-4.1) 1.00
Metro/urban/rural status
Metropolitan 98,701 30.5y (30.3-30.7) 1.20 (1.18-1.22) 79,303 24.5y (24.4-24.7) 1.25 (1.23-1.27) 12,637 3.8y (3.8-3.9) 1.05 (1.01-1.10)
Urban 19,743 25.4 (25.1-25.8) 1.00 15,216 19.7 (19.4-20.0) 1.00 2874 3.6 (3.5-3.8) 1.00
Rural 2472 23.2y (22.3-24.2) 0.91 (0.87-0.95) 1837 17.2y (16.4-18.0) 0.87 (0.83-0.92) 407 3.8 (3.5-4.2) 1.05 (0.94-1.17)
Rates are per 100,000 and age-adjusted to 2000 US Standard Population (19 age groups; Census P25-1130) standard. Data are from 44 population-based cancer registries that participate in Centers
for Disease Control and Prevention National Program of Cancer Registries and National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) programs and provide county-level
incidence data.
Stage was coded using Collaborative Stage; data were recoded into Derived SEER Summary Stage 2000 for 2004 to 2006.
CI, Confidence interval; N/A, not applicable.
*Race-specific county-level characteristics were used.
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estimates.43,44 The exponentials of the coefficients
estimated in the models were interpreted as inci-
dence density ratios. This measure of effect, some-
times also called a rate ratio, was the ratio of the
numbers of observed divided by expected cases in a
group of interest to the numbers of observed divided
by expected cases in a referent group. Interactions
between race/ethnicity and each SES variable were
examined to determine if the relationship between
SES and cancer IR was similar across race groups.
There were no meaningful interactions, so these
terms were dropped from the models (results not
shown).
RESULTS
A total of 130,359 melanoma cases reported from
44 registries met our inclusion criteria for diagnosis
years 2004 to 2006. Of these, 10,002 (7.6%) cases
were unstaged; 73,818 (56.6%) were male and 56,541
(43.4%) were female. The majority of the cases (93%)
were non-Hispanic white.
Age-adjusted melanoma IRs, rate ratios, and 95%
CI by race/ethnicity and county-level SES measures
for all cases, early-stage cases, and late-stage cases
are presented in Table I. The overall age-adjusted
melanoma IRs were 24.2 per 100,000; with 30.2 per
100,000 for males and 19.9 per 100,000 for females.
The majority of the melanoma incidence cases were
non-Hispanics whites (n = 121,253) with the highest
IR (IR 29.4) compared with all other race/ethnicity
groups. The IR among Hispanic whites (IR 5.9),
blacks (IR 1.3), American Indian/Alaska Natives (IR
5.7), and Asian/Pacific Islanders (IR 1.8) was 80%,
96%, 81%, and 94% lower than non-Hispanic whites,
respectively. Similarly, for cases diagnosed at early
stage, noneHispanic whites had the highest rate (IR
23.5) among all race/ethnic groups. The IR among
Hispanic whites (IR 4.2), blacks (IR 0.7), American
Indian/Alaska Natives (IR 3.6), and Asian/Pacific
Islanders (IR 1.2) was 82%, 97%, 85%, and 95% lower
than non-Hispanic white group, respectively. For
cases diagnosed at late stage, rates were 69%, 88%,
65%, and 86% lower in Hispanic whites (IR 1.2),
blacks (IR 0.5), American Indian/Alaska Natives
(IR 1.3), and Asian/Pacific Islanders (IR 0.5) than
non-Hispanic whites (IR 3.8), respectively. The IR
ratios indicate that these racial differences were
statistically significant for all cases, and for cases
with early- and late-stage disease (Table I).
For all cases, those living in counties with low
poverty level had the highest incidence of melanoma
(IR 27.6). The rate of melanoma in counties with high
poverty level was about 40% lower than counties
with low poverty for all cases and early-stagemelanoma and about 26% lower for late-stage mela-
noma. Comparing education categories, IRs were
highest in counties with high education level for all
cases (IR 28.2), for early-stagemelanoma (IR 22.5), and
for late-stage melanoma (IR 3.4). The melanoma IR in
counties at low education level was about 47% lower
for all cases and early-stage melanoma and 20% lower
for late-stage melanoma, when compared with
countieswith high education level. Examiningmedian
household income, melanoma rates were highest
among counties with high median household income
for all cases, early-stage melanoma, and late-stage
melanoma. Rates were also highest among counties
with low unemployment for all cases, early-stage
melanoma, and late-stage melanoma. Rates of mela-
noma incidence were higher among residents of met-
ropolitan area counties (IR 24.4) than urban or rural
counties. These resultswere consistent for all cases and
early-stage disease. For late-stage melanoma, IRs were
lower in metropolitan counties (IR 3.1) than urban
counties. Early-stage melanoma IRs were higher than
late stage across all the SES and race/ethnicity groups.
In addition, when the rates by SES variables were
compared among males and females, they were
significantly higher among males than females in
all SES measures. The rates of melanoma incidence
were not presented separately for males and females
as the SES measures are all area-based and not
separated by gender.
Table II shows age-adjusted IRs, rate ratios, and
95% CI for non-Hispanic whites using county-level
measures for household income and unemployment
and race-specific county-level measures for poverty
and education. The results are limited to non-
Hispanic whites as the numbers of cases for other
race/ethnic groups are too small for stable estimates.
For all cases, IRs were significantly higher for
counties with low poverty (IR 30.6), high level of
education (IR 32.1), high median household income
(IR 35.0), low unemployment (IR 30.1), and metro-
politan status (IR 30.5). Patterns of IRs for early-stage
melanoma were similar. Counties with lower pov-
erty, greater education, greater income, low unem-
ployment, and metropolitan status had increased
incidence. For late stage, counties with low poverty,
higher education, and higher median income had
increased incidence of melanoma. However, IRs did
not differ significantly by county unemployment or
metro/urban/rural status.
Table III shows results from themultilevel Poisson
regression models for all melanoma cases and for
early and late stage for all race/ethnicity groups. For
both the all cases and early-stage models, non-
Hispanic white race, lower poverty, higher high
school education, higher median household income,
Table III. Multivariable adjusted incidence density ratio and 95% confidence interval for all melanoma cases,
early-stage melanoma, and late-stage melanoma for all race/ethnicity groups using multilevel Poisson
regression models, United States 2004 to 2006
Characteristics
All cases Early stage Late stage
IDR (95% CI) P value IDR (95% CI) P value IDR (95% CI) P value
Race \.0001 \.0001 \.0001
Non-Hispanic white 1.00 1.00 1.00
Hispanic white 0.22 (0.20-0.23) 0.19 (0.18-0.21) 0.29 (0.25-0.33)
Black 0.05 (0.05-0.05) 0.03 (0.03-0.04) 0.12 (0.10-0.14)
American Indian/Alaska
Native
0.24 (0.21-0.27) 0.21 (0.18-0.24) 0.32 (0.24-0.44)
Asian Pacific Islander 0.05 (0.04-0.05) 0.04 (0.03-0.04) 0.11 (0.09-0.14)
Below poverty level, %* \.0001 \.0001 .6763
Low (\10%) 1.00 1.00 1.00
Medium (10%-\20%) 0.98 (0.96-1.00) 0.98 (0.96-1.00) 0.99 (0.93-1.04)
High ($ 20%) 0.85 (0.80-0.89) 0.82 (0.77-0.87) 0.95 (0.83-1.07)
High school education, %* \.0001 \.0001 .4135
Low (\75%) 1.00 1.00 1.00
Medium (75%-\85%) 1.13 (1.10-1.16) 1.15 (1.12-1.19) 1.01 (0.95-1.08)
High ($ 85%) 1.24 (1.20-1.27) 1.26 (1.21-1.30) 1.04 (0.96-1.12)
Median household income \.0001 \.0001 .2164
Low (\$35,000) 1.00 1.00 1.00
Medium ($35,000-\$50,000) 1.03 (1.01-1.06) 1.05 (1.02-1.08) 1.02 (0.96-1.08)
High ($ $50,000) 1.09 (1.06-1.13) 1.13 (1.09-1.17) 1.06 (0.98-1.15)
Unemployed, % \.0001 \.0001 .7340
Low (\5%) 1.22 (1.17-1.27) 1.27 (1.22-1.33) 1.03 (0.94-1.13)
Medium (5%-10%) 1.17 (1.13-1.22) 1.23 (1.18-1.28) 1.03 (0.95-1.13)
High ([10%) 1.00 1.00 1.00
Metro/urban/rural status .5622 .1515 .1326
Metropolitan 0.99 (0.97-1.01) 1.01(0.99-1.03) 0.96 (0.92-1.01)
Urban 1.00 1.00 1.00
Rural 0.98 (0.94-1.02) 0.96 (0.92-1.01) 1.06 (0.95-1.17)
IDRs were computed using SAS Proc Glimmix (SAS Institute Inc, Cary, NC) multilevel regression analyses. All IDRs are adjusted for age,
gender, and all characteristics included in table. Data are from 44 population-based cancer registries that participate in Centers for Disease
Control and Prevention National Program of Cancer Registries and National Cancer Institute Surveillance, Epidemiology, and End Results
(SEER) programs and provide county-level incidence data.
Stage was coded using Collaborative Stage; data were recoded into Derived SEER Summary Stage 2000 for 2004 to 2006.
CI, Confidence interval; IDR, incidence density ratio.
*Race-specific county-level characteristics were used.
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effects adjusted for all other variables in the models.
Those residing in counties with 10% or more race-
specific poverty status had decreased risk of cancer
incidence relative to those residing in counties with
less than 10% race-specific poverty status. Those
residing in counties with race-specific high school
education rates greater than or equal to 75%, with
county-level median household income of greater
than or equal to 35,000, and unemployment rate of
less than 10% had increased cancer incidence rela-
tive to those in the lowest education, income, and
employment categories, respectively. Melanoma in-
cidence did not vary significantly by county metro/
urban/rural status for either the all cases or early-
stage models.In the model for late-stage disease, when all the
covariates were included, only race was significant;
non-Hispanic whites had higher incidence relative to
Hispanic whites, blacks, American Indian/Alaska
Natives, and Asian and Pacific Islanders.
Table IV shows results from themultilevel Poisson
regression models for all melanoma cases and for
early and late stage for non-Hispanicwhites. For both
the all cases and early-stage models, lower poverty,
higher high school education, higher median house-
hold income, and lower unemployment showed
higher IRs. County metro/urban/rural status was
not statistically significant in either model. All effects
were adjusted for all other variables in the models.
Non-Hispanic whites residing in counties with
high poverty status had decreased risk of all stage
Table IV. Multivariable adjusted incidence density ratio and 95% confidence interval for all melanoma cases,
early-stage melanoma, and late-stage melanoma among non-Hispanic whites using multilevel Poisson
regression models, United States 2004 to 2006
Characteristics
All cases Early stage Late stage
IDR (CI) P value IDR (CI) P value IDR (CI) P value
Below poverty level, %* \.0001 \.0001 .7628
Low (\10%) 1.00 1.00 1.00
Medium (10%-\20%) 0.98 (0.96-1.00) 0.98 (0.95-1.00) 0.99 (0.93-1.04)
High ($ 20%) 0.84 (0.79-0.90) 0.84 (0.78-0.91) 0.94 (0.80-1.12)
High school education, %* \.0001 \.0001 .5143
Low (\75%) 1.00 1.00 1.00
Medium (75%-\85%) 1.13 (1.10-1.16) 1.15 (1.11-1.18) 1.00 (0.93-1.07)
High ($ 85%) 1.23 (1.19-1.27) 1.24 (1.20-1.29) 1.03 (0.95-1.11)
Median household income \.0001 \.0001 .1972
Low (\$35,000) 1.00 1.00 1.00
Medium ($35,000-\$50,000) 1.04 (1.02-1.07) 1.06 (1.03-1.09) 1.02 (0.96-1.08)
High ($ $50,000) 1.10 (1.07-1.14) 1.14 (1.10-1.18) 1.06 (0.98-1.16)
Unemployed, % \.0001 \.001 .5970
Low (\5%) 1.22 (1.17-1.27) 1.28 (1.22-1.34) 1.03 (0.94-1.14)
Medium (5%-10%) 1.17 (1.13-1.22) 1.22 (1.17-1.27) 1.04 (0.95-1.15)
High ([10%) 1.00 1.00 1.00
Metro/urban/rural status .7733 .0781 .1139
Metropolitan 1.00 (0.98-1.01) 1.01 (0.99-1.04) 0.96 (0.92-1.01)
Urban 1.00 1.00 1.00
Rural 0.99 (0.95-1.03) 0.96 (0.91-1.01) 1.06 (0.96-1.18)
IDRs were computed using SAS Proc Glimmix (SAS Institute Inc, Cary, NC) multilevel regression analyses. All IDRs are adjusted for age,
gender, and all characteristics included in table. Data are from 44 population-based cancer registries that participate in Centers for Disease
Control and Prevention National Program of Cancer Registries and National Cancer Institute Surveillance, Epidemiology, and End Results
(SEER) programs and provide county-level incidence data.
Stage was coded using Collaborative Stage; data were recoded into Derived SEER Summary Stage 2000 for 2004 to 2006.
CI, Confidence interval; IDR, incidence density ratio.
*Race-specific county-level characteristics were used.
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Hispanic whites residing in counties with low pov-
erty status. Non-Hispanic whites residing in counties
with high school education greater than or equal to
75%, median household income of greater than or
equal to $35,000, and less than 10% unemployed
had increased melanoma incidence. For late-stage
melanoma incidence, the SES factors we investi-
gated were not significant among non-Hispanic
whites.
DISCUSSION
Our analysis showed that melanoma incidence
was associated with county-level socioeconomic
measures. Our findings include increased melanoma
incidence in counties with low poverty, higher
median income, low unemployment, and higher
percentage of people with at least a high school
education. Incidence was highest among non-
Hispanic whites, and remained significant for all
cases and early-stage melanoma cases within this
race/ethnicity group after adjusting for SES. The
findings were similar for all cases, early-stagemelanoma, and late-stage melanoma in univariate
models; however, after adjustment for other varia-
bles the associations for county SES and for late-stage
melanoma were no longer significant. Higher inci-
dence was also observed for those residing in met-
ropolitan counties for all cases and early-stage cases.
However, the associations were not significant after
adjusting for other variables.
These findings corroborate many results from
earlier studies on SES and melanoma incidence,
which have shown that lower poverty, higher edu-
cation, higher income, lower unemployment, and
metropolitan counties have increasedmelanoma IRs.
For example, an extensive review by Reyes-Ortiz
et al15 summarizing the literature on SES melanoma
incidence concluded that melanoma is more com-
mon in high SES than in low SES populations and low
SES populations present with later stage at diagnosis.
In a more recent report using SEER data, Clegg et al4
reported that compared with those with a college
education, those with less than high school educa-
tion had a reduced risk of melanoma of the skin.
Other studies using different SES measures, such as
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reported similar findings. Data from British cancer
registries using the Index of Multiple Deprivation
reported the lowest incidence of melanoma for the
most deprived patients.45
Althoughour findingswere similar for all cases and
early-stage cases, likely because of preponderance of
early-stage cases among all cases, we could not
confirm increased diagnosis with late stage among
lower SES groups as reported previously. In contrast
to several earlier studies, we found lower SES groups
did not exhibit later stage at diagnosis as compared
with higher SES groups. Previous melanoma studies
have an association of more advance disease with
lower SES. A study of California Medicaid enrollment
and melanoma stage at diagnosis showed that indi-
viduals in the lower SES quintiles had increased odds
for late-stage diagnosis.16 In addition, a review by
Reyes-Ortiz et al15 found that all 12 studies identified
investigating SES and advanced stage and all 9 studies
of SES and melanoma survival supported poorer
outcomes with low SES. Reyes-Ortiz et al15 described
a negative SES gradient with melanoma stage at
diagnosis and found that low SES and uninsured
populations had later stage at diagnosis ofmelanoma.
Their review supported a weaker association be-
tween SES and melanoma stage at diagnosis in coun-
tries with a universal health care system. Access to
health care, availability of information about screen-
ing, and anatomic location of the lesion are possible
explanations for this association. Based on their
review of earlier reports, patients with low SES or
without health insurance were less likely to undergo
screening and lower SES was associated with less
knowledge and awareness of melanoma. Unlike our
results, Greenlee andHowe14 reported higher county
poverty associated with distant-stage melanoma us-
ing cancer registry data.
Differences in methodology, population, and
study outcome variables may be partial and possible
explanations for these differences in the association
of SES with melanoma outcomes in our study com-
pared with the existing literature. In our study the
distribution of unstaged cases was similar across all
categories of SES measures and does not seem to
have an effect on our findings. For example, the
study by Greenlee and Howe14 was based on data
from 1997 to 2000, used only 57% of US population
data and examined association with distant-stage
cases (as compared with regional and distant-stage
cases) and a more extreme poverty cut point ([30%
below poverty).
Several possible explanations can be hypothe-
sized for increased incidence among higher SES
populations. Some have argued the increasedmelanoma incidence is a result of greater UV
radiationeinduced carcinogenesis.46 We did not ac-
count for UV exposure in our analyses; however,
details of including adjustment for UV exposure are
included in a separate article in this supplement.47 It
is possible that those with higher SES are more likely
to be engaged in certain behaviors or activities such
as time spent outdoors for leisure activities, or be
influenced by collective social definitions of beauty
and body image prompting tanning bed use or
outdoor tanning.46,48-50 Another reason could be
that those with higher SES are using health care
services frequently and are screened more often.15,51
Strengths and limitations
This analysis makes a significant contribution to
the literature by providing a national assessment of
melanoma incidence using available cancer regis-
tries including greater coverage of the United States,
using 3 consecutive, combined years of data.
However, several limitations should be noted.
Because cancer registries do not collect individual-
level measures of SES, we were limited to using
aggregate county-level SES measures of poverty,
median income, and the percent of high school
education to characterize the SES of the area inwhich
individuals resided at the time of cancer diagnosis.
One possibility is to use finer-level area-based mea-
sures such as census tractelevel characteristics for
examining SES-melanoma associations; however,
census tract information is available for only approx-
imately 60% of records in United States cancer
registry data.52
Underreporting ofmelanoma is commonas a large
percentage of melanoma may be diagnosed in out-
patient settings.53,54 In addition, central cancer regis-
tries from different states may have differences in
reporting practices.We attempted to account for such
differences by including state random effects, how-
ever, unadjusted confounding caused by such ran-
dom effects cannot be ruled out. We could not
expandour detailed analyses to race/ethnicity groups
other than non-Hispanic whites because of very
limited numbers of cases. Therefore, our SES results
cannot be generalized to other race/ethnicity groups.
To our knowledge, this study is the first to report
on the association between SES and melanoma
incidence using nationally generated data that in-
clude a majority of the US population. To address the
burden of melanoma borne by particular popula-
tions, future interventions may focus on higher SES
groups traditionally considered informed with high
health literacy equating to fewer disparities, a greater
quality of life, and improved health outcomes.
Although this study covers a large proportion of
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S58.e11 Singh et althe US population, additional and improved data
collection (eg, improved completeness of melanoma
case or collection of individual-level SES and census
tract information) through cancer registries will be
essential in continued monitoring of the burden of
melanoma in all areas of the United States.REFERENCES
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